Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Adenosine-5'-carboxylic Acid | An intermediate in the synthesis of Adenosine 5'-Monophosphate-5',5''-d2 Disodium Salt. Group: Pharmaceutical. CAS No. 3415-9-6. Pack Sizes: 200 mg. Product ID: B2000-218147. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Adenosine-5'-monophosphate disodium salt (AMP) | 25g Pack Size. Group: Biochemicals, Building Blocks, Diagnostic Raw Materials. Formula: C10H12N5Na2O7P. CAS No. 4578-31-8. Prepack ID : 41595662-25g. Molecular Weight : 391.18. |  |
| Adenosine 5'-monophosphomorpholidate 4-morpholine-N,N'-dicyclohexylcarboxamidine salt | Adenosine 5'-monophosphomorpholidate 4-morpholine-N,N'-dicyclohexylcarboxamidine salt is an intermediate in the Flavine Adenine Dinucleotide synthesis. Group: Pharmaceutical. CAS No. 24558-92-7. Pack Sizes: 50 mg. Product ID: B2001-111086. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Adenosine-5-triphosphate disodium salt (ATP) | 5g Pack Size. Group: Biochemicals. Formula: C10H14N5Na2O13P3. CAS No. 987-65-5. Prepack ID : 16368689-5g. Molecular Weight : 551.14. | |
| Adenosine-5-triphosphate disodium salt hydrate | 25g Pack Size. Group: Analytical Reagents, Biochemicals, Building Blocks. Formula: C10H14N5Na2O13P3 · xH2O. CAS No. 34369-07-8. Prepack ID : 90018841-25g. Molecular Weight : 551.14. | |
| Adenosine-5'-triphosphate disodium salt trihydrate | 5g Pack Size. Group: Analytical Reagents, Biochemicals, Diagnostic Raw Materials. Formula: C10H14N5O13P3Na2 · xH2O. CAS No. 51963-61-2. Prepack ID : 49306151-5g. Molecular Weight : 551.14. | |
| ADENOSINE-5-TRIPHOSPHORIC ACID | ADENOSINE-5-TRIPHOSPHORIC ACID, UK suppliers of laboratory chemicals and apparatus needed |  |
| 2-Amino-3'-O-(2-methoxyethyl)adenosine | 2-Amino-3'-O-(2-methoxyethyl)adenosine, a highly potent adenosine receptor agonist, finds extensive utility in biomedical research. Esteemed for its exceptional capabilities, this compound demonstrates remarkable promise in combating diverse ailments. Group: Pharmaceutical. CAS No. 256224-02-9. Pack Sizes: 100 mg. Product ID: B2000-242149. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-O-(2-Methoxyethyl)adenosine | It is a derivative of adenosine that acts as a building block for crosslinking oligonucleotides. Group: Pharmaceutical. CAS No. 168427-74-5. Pack Sizes: 1 g. Product ID: B2706-051664. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-tBDSilyl Adenosine (n-PAC) CED phosphoramidite | 2'-tBDSilyl Adenosine (n-PAC) CED Phosphoramidite is a specialized reagent used in oligonucleotide synthesis. It incorporates a 2'-tert-butyldimethylsilyl (tBDSilyl) group onto the adenosine (A) nucleoside at the 2'-position. Additionally, it features a nitrilotriacetic acid (n-PAC) group for chelating metal ions and a controlled-efficiency (CED) phosphoramidite for efficient incorporation during solid-phase synthesis. This reagent enables the production of modified RNA oligonucleotides with improved stability and functionality, suitable for various molecular biology and biotechnology applications, including RNA interference and gene expression studies. Group: Pharmaceutical. CAS No. 121058-86-4. Pack Sizes: 1 g. Product ID: B1370-008561. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-O-DMT-N6-Benzoyl-Adenosine TNA 2'-CE phosphoramidite | 3'-O-DMT-N6-Benzoyl-Adenosine TNA 2'-CE phosphoramidite is a modified nucleotide used in the synthesis of Threose Nucleic Acid (TNA) molecules for biomedical research. TNA is a promising alternative to DNA and RNA for gene and drug delivery due to its chemical stability and resistance to nuclease degradation. This specific phosphoramidite derivative incorporates a benzoyl-adenosine moiety, making it ideal for designing TNA-based drugs for the treatment of viral infections, inflammatory diseases, and cancer. Group: Pharmaceutical. CAS No. 329683-93-0. Pack Sizes: 1 g. Product ID: 329683-93-0. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-2'-O-tBDMS-N1-Methyl-N6-chloroacetyl-adenosine 3'-CE phosphoramidite | 5'-O-DMT-2'-O-tBDMS-N1-Methyl-N6-chloroacetyl-adenosine 3'-CE phosphoramidite, an essential instrument employed in scientific inquiry and pharmaceutical exploration, exhibits an exceptionally intricate nature. Primarily, this remarkable compound facilitates the creation of tailored DNA fragments, thereby accommodating a diverse range of research endeavors involving gene therapy and pharmaceutical conveyance mechanisms. Notably, our product assumes a pivotal role in the design and fabrication of nucleotide analogs, which serve as targeted interventions for critical maladies, including malignancies, viral infestations, and hereditary abnormalities. Group: Pharmaceutical. Pack Sizes: 1 g. Product ID: B1370-095533. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-2'-O-TBDMS-N6-Benzoyl-L-Adenosine 3'-CE phosphoramidite | 5'-O-DMT-2'-O-TBDMS-N6-Benzoyl-L-Adenosine 3'-CE phosphoramidite is a crucial reagent used in the synthesis of oligonucleotides for biomedical research. It enables the efficient introduction of N6-benzoyl-L-Adenosine residues into the oligonucleotide chain, thus allowing the study of adenosine-modified nucleic acids. This product finds applications in drug discovery, gene therapy, and understanding diseases related to adenosine signaling pathways. Group: Pharmaceutical. CAS No. 1803193-36-3. Pack Sizes: 1 g. Product ID: B1370-291981. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-3'-O-TBDMS-N6-Benzoyl-Adenosine 2'-CE phosphoramidite | 5'-O-DMT-3'-O-TBDMS-N6-Benzoyl-Adenosine 2'-CE phosphoramidite is an antiviral nucleoside phosphoramidite for DNA synthesis. Group: Pharmaceutical. CAS No. 129451-75-8. Pack Sizes: 1 g. Product ID: B1370-291969. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Adenosine | 100g Pack Size. Group: Biochemicals. Formula: C10H13N5O4. CAS No. 58-61-7. Prepack ID : 20213653-100g. Molecular Weight : 267.25. | |
| D-Adenosine | 25g Pack Size. Group: Biochemicals. Formula: C10H13N5O4. CAS No. 58-61-7. Prepack ID : 20213653-25g. Molecular Weight : 267.25. | |
| N6-(2-Hydroxyethyl)adenosine | It is an anticonvulsant by activating the adenosine A1 receptor (AA1R). Group: Pharmaceutical. CAS No. 4338-48-1. Pack Sizes: 5 g. Product ID: B1370-144826. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N6-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)adenosine 3'-CE phosphoramidite | N6-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)adenosine 3'-CE phosphoramidite is used to incorporate 2'-O-methoxyethyl-modified A into oligonucleotide phosphoramidites, which is useful for antisense RNA. The 2'-MOE backbone provides stronger duplex stability, significant nuclease resistance and relatively low toxicity. Group: Pharmaceutical. CAS No. 251647-53-7. Pack Sizes: 1 g. Product ID: B2706-291983. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N6-Benzyl Adenosine | A selective A1 adenosine receptor agonist. Group: Pharmaceutical. CAS No. 4294-16-0. Pack Sizes: 10 g. Product ID: B2706-317295. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N6-(cis-hydroxyisopentenyl)adenosine | N6-(cis-hydroxyisopentenyl)adenosine is a remarkable biochemical compound, used for studying an array of ailments and circumstances including breast and lung cancer. Swiftly, it embraces anti-inflammatory traits thus used for studying diseases of inflammation, particularly the notorious rheumatoid arthritis. Group: Pharmaceutical. CAS No. 15896-46-5. Pack Sizes: 5 mg. Product ID: B1370-001245. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite is a classic protected 2-OTBDMS phosphoramidite used to incorporate nucleoside A into the synthesis of oligonucleotides. Group: Pharmaceutical. CAS No. 104992-55-4. Pack Sizes: 25 g. Product ID: B2706-081243. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid Ammonium Salt | 1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid Ammonium Salt is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 2227107-89-1. Pack Sizes: 5 mg. Product ID: B2694-352395. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-MeCCPA | 2'-MeCCPA is a potent and highly selective agonist at A1 adenosine receptors (Ki= 3.3, 9580, 37600 and 1150 nM for human recombinant A1, A2A, A2B and A3 receptors respectively). Group: Pharmaceutical. CAS No. 205171-12-6. Pack Sizes: 10 mg. Product ID: B1370-115137. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-Desmethoxy Omeprazole Sulfide | 4-Desmethoxy Omeprazole Sulfide is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 704910-89-4. Pack Sizes: 10 mg. Product ID: B0139-478367. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-Hydroxy Omeprazole Sodium Salt | 4-Hydroxy Omeprazole Sodium Salt is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 1803449-15-1. Pack Sizes: 5 mg. Product ID: B0139-007869. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-O-Desmethyl Omeprazole | 5-O-Desmethyl Omeprazole is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: A metabolite of omeprazole, an antiulcerative. Group: Pharmaceutical. CAS No. 151602-49-2. Pack Sizes: 10 mg. Product ID: B1370-050380. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Hydroxykaempferol 3,6-diglucoside | 6-Hydroxykaempferol 3,6-diglucoside is a flavonoid compound isolated and purified from the herbs of Chrysactinia tinctorius. It shows weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation. Group: Pharmaceutical. CAS No. 142674-16-6. Pack Sizes: 5 mg. Product ID: B0005-479853. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AB928 | AB928 is a dual antagonist of the A2aR and A2bR adenosine receptors with Kb of 1.5 and 2.0 nM, respectively. It potently blocks the immunosuppressive effects of high adenosine concentrations in the tumor microenvironment. Group: Pharmaceutical. CAS No. 2239273-34-6. Pack Sizes: 50 mg. Product ID: B2693-334167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ABT 702 Dihydrochloride | ABT 702 Dihydrochloride is a potent and selective non-nucleoside adenosine kinase inhibitor with IC50 value of 1.7 nM. ABT 702 displays oral activity in animal models of pain and inflammation. In Mar 2005, ABT 702 was discontinued preclinical for Pain and Rheumatoid arthritis in USA. Uses: Anti-inflammation. Group: Pharmaceutical. CAS No. 1188890-28-9. Pack Sizes: 50 mg. Product ID: B2693-475131. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Apadenoson Impurities | Apadenoson Impurities, essential constituents, play a critical role in Apadenoson research and quality control, a selective A2A adenosine receptor agonist. This compound is under scrutiny for its potential therapeutic efficacy in stress testing for coronary artery disease, advancing cardiovascular and pulmonary therapy investigations significantly. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Atractyloside potassium salt | Atractyloside potassium salt is the potassium salt of atractyloside, which inhibits oxidative phosphorylation by blocking the transfer of adenosine nucleotides through the mitochondrial membrane. Uses: Inhibitor of the adenine nucleotide translocator (ant). Group: Pharmaceutical. CAS No. 102130-43-8. Pack Sizes: 20 mg. Product ID: B0005-158965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AZD-4635 | AZD-4635 is an orally available adenosine 2A receptor (A2AR) inhibitor. Group: Pharmaceutical. CAS No. 1321514-06-0. Pack Sizes: 25 mg. Product ID: B0084-260293. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bedaquiline fumarate | Bedaquiline fumarate is an anti-tuberculosis drug which selectively inhibits the mycobacterial energy metabolism and found to be effective against all states of Mycobacterium tuberculosis. It possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase. It has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis, however, its side effect profile limits its use against MDR-TB when no other effective regimen can be provided. Uses: Antitubercular agents. Group: Pharmaceutical. CAS No. 845533-86-0. Pack Sizes: 200 mg. Product ID: B0084-463644. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| β-Nicotinamide Adenine Dinucleotide | NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It plays a role in the activity of several enzymes, such as poly(ADP)-ribose polymerases and cADP-ribose synthases. NAD+ is commonly used as an oxidizing agent. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 53-84-9. Pack Sizes: 10 g. Product ID: B0084-094034. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| beta-Nicotinamide adenine dinucleotide phosphate | NADP zwitterion is a NADP. It has a role as a fundamental metabolite. It is a conjugate base of a NADP(+). A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). Group: Pharmaceutical. CAS No. 53-59-8. Pack Sizes: 50 g. Product ID: B1370-093984. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Binodenoson | Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A2A receptor agonist. It is used to diagnose coronary artery disease. Uses: Purinergic p1 receptor agonists. Group: Pharmaceutical. CAS No. 144348-08-3. Pack Sizes: 10 mg. Product ID: B1370-078439. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Caffeine Impurity F | Paraxanthine is a metabolite of caffeine, and also acts as an inhibitor of phosphodiesterase 9 (PDE9) and an antagonist of adenosine receptors A1 and A2 (Kis = 35 and 22 μM, respectively in equine forebrain tissues). Group: Pharmaceutical. CAS No. 611-59-6. Pack Sizes: 200 mg. Product ID: B0084-129330. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CF-101 | CF101 is a specific agonist to the A3 adenosine receptor, which inhibits the development of colon carcinoma growth in cell cultures and xenograft murine models. CF101 has been shown to downregulate PKB/Akt and NF-κB protein expression level. CF101 potentiates the cytotoxic effect of 5-FU, thus preventing drug resistance. The myeloprotective effect of CF101 suggests its development as an add-on treatment to 5-FU. Group: Pharmaceutical. CAS No. 152918-18-8. Pack Sizes: 50 mg. Product ID: B2693-256549. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CGS 15943 | CGS 15943 is a potent and orally bioactive adenosine receptor antagonist (Ki = 3.5, 4.2, 16 and 51 nM for human A1, A2A, A2B and A3 receptors, respectively). Group: Pharmaceutical. CAS No. 104615-18-1. Pack Sizes: 100 mg. Product ID: B2693-159610. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cladribine | 2-Chloro-2'-deoxyadenosine is an analog of adenosine that is resistant to both proliferating and non-dividing lymphocytes (IC50 = 45 nM). When phosphorylated, 2-Chloro-2'-deoxyadenosine accumulates in cells and inhibits ribonucleotide reductase. Group: Pharmaceutical. CAS No. 4291-63-8. Pack Sizes: 1 g. Product ID: B2693-004182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CPI-444 | CPI-444 is a potent, orally available, selective antagonist of the adenosine A2A receptor that has been well tolerated in Ph 1/1b studies in non-oncology indications. Group: Pharmaceutical. CAS No. 1202402-40-1. Pack Sizes: 20 mg. Product ID: B0084-007707. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginkgolide C | Ginkgolide C, extracted from the Ginkgo biloba leaves, a traditional Chinese medicine, significantly increases the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), and studies showed that when platelets (108/ml. Group: Pharmaceutical. CAS No. 15291-76-6. Pack Sizes: 20 mg. Product ID: NP1518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Istradefylline | Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist (Ki=2.2 nM). Uses: Adenosine a2 receptor antagonists. Group: Pharmaceutical. CAS No. 155270-99-8. Pack Sizes: 500 mg. Product ID: B0084-084866. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Istradefylline Impurities | Istradefylline Impurities hold a critical function in the qualitative assessment of Istradefylline, an adenosine A2A receptor antagonist targeting Parkinson's therapeutics. These impurities are vital in drug formulation and regulatory adherence, guaranteeing pharmaceutical integrity and the safety of medicinal products, thereby underpinning therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl Omeprazole Impurity 1 | N-Methyl Omeprazole Impurity 1 is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 89352-76-1. Pack Sizes: 100 mg. Product ID: B2694-262914. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole | Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: Anti-ulcer agents; enzyme inhibitors. Group: Pharmaceutical. CAS No. 73590-58-6. Pack Sizes: 25 g. Product ID: BBF-04530. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity B | Omeprazole EP Impurity B is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 110374-16-8. Pack Sizes: 50 mg. Product ID: B0139-478368. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity C | Omeprazole EP Impurity C is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: It is used in the production of the gastric proton pump inhibitors, omeprazole and esomeprazole. Group: Pharmaceutical. CAS No. 73590-85-9. Pack Sizes: 500 mg. Product ID: B0084-474824. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity D | Omeprazole EP Impurity D is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: Omeprazole sulphone acts as a reversible direct-acting and metabolism-dependent inhibitor of cyp2c19. Group: Pharmaceutical. CAS No. 88546-55-8. Pack Sizes: 25 mg. Product ID: B0084-474888. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity E | Omeprazole EP Impurity E is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 176219-04-8. Pack Sizes: 50 mg. Product ID: B0139-478362. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity F | Omeprazole EP Impurity F is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 125656-82-8. Pack Sizes: 5 mg. Product ID: B0139-478372. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity G | Omeprazole EP Impurity G is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 125656-83-9. Pack Sizes: 5 mg. Product ID: B0139-478373. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity H | Omeprazole EP Impurity H is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 863029-89-4. Pack Sizes: 2.5 mg. Product ID: B0139-478369. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole EP Impurity I | Omeprazole EP Impurity I is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 158812-85-2. Pack Sizes: 25 mg. Product ID: B0139-478361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole Impurity 13 | Omeprazole Impurity 13 is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 220757-74-4. Pack Sizes: 2 mg. Product ID: B2694-102750. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole Related Compound 10 | Omeprazole Related Compound 10 is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Group: Pharmaceutical. CAS No. 142885-92-5. Pack Sizes: 25 mg. Product ID: B0139-007867. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omeprazole Related Compound 15 | Omeprazole Related Compound 15 is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: Impurity c from the synthesis of omeprazole. Group: Pharmaceutical. CAS No. 317807-10-6. Pack Sizes: 5 mg. Product ID: B0139-107560. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Preladenant | Preladenant is a potent adenosine A2 receptor antagonist that has been studied as a therapeutic agent for Parkinson's disease. Group: Pharmaceutical. CAS No. 377727-87-2. Pack Sizes: 1 g. Product ID: B0084-459102. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regadenoson | Regadenoson, as a coronary vasodilator it is a selective A2A adenosine receptor agonist in myocardial imaging. Uses: A selective a2a adenosine receptor agonist in myocardial imaging. Group: Pharmaceutical. CAS No. 313348-27-5. Pack Sizes: 25 mg. Product ID: B0084-107114. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-Omeprazole Sodium Salt | (R)-Omeprazole Sodium Salt is an impurity of Omeprazole. Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia. It binds to the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase) and inhibits its activity and the parietal cell secretion of H+ ions into the gastric lumen. Uses: R-form of omeprazole. gastric proton-pump inhibitor. Group: Pharmaceutical. CAS No. 161796-77-6. Pack Sizes: 5 mg. Product ID: B0139-263395. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SCH 58261 | SCH 58261 is a potent and selective antagonist of adenosine A2A receptor, displaying neuroprotective activity. Uses: Adenosine a2 receptor antagonists. Group: Pharmaceutical. CAS No. 160098-96-4. Pack Sizes: 25 mg. Product ID: B0084-211078. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toyocamycin | Toyocamycin is a pyrrolopyrimidine nucleoside isolated from streptomyces toyocaensis, and also an adenosine nucleotide antimetabolite. It has a broad spectrum of action against bacteria, fungi, protozoans and mammalian cell lines. Uses: Antimetabolites, antineoplastic. Group: Pharmaceutical. CAS No. 606-58-6. Pack Sizes: 100 mg. Product ID: BBF-03421. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tubercidin | Tubercidin is an adenosine analog with antiviral, antitrypanosomal, and antifungal properties. It inhibits DNA/RNA synthesis and other metabolic processes. Uses: 7-deaza-adenosine is an adenosine analog. Group: Pharmaceutical. CAS No. 69-33-0. Pack Sizes: 500 mg. Product ID: BBF-03427. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VER-155008 | VER-155008 is an adenosine-derived inhibitor of heat shock protein 70 (Hsp70; IC50 = 0.5 μM) that is selective over Hsp90. It targets the nucleotide-binding domain (NBD) of Hsp70 and similarly binds the NBDs of Hsp70 cognates Hsc70 (Ki = 10 μM) and glucose-regulated protein 78 (Grp78; KD = 80 nM). VER-155008 inhibits the proliferation of human breast and colon cancer cell lines, inducing apoptosis or caspase-independent cell death. It induces the proteasome-dependent degradation of Hsp90 client proteins and potentiates the apoptotic activity of Hsp90 inhibitors. VER-15508 also triggers paraptosis in anaplastic thyroid carcinoma cells. Group: Pharmaceutical. CAS No. 1134156-31-2. Pack Sizes: 100 mg. Product ID: B1370-272446. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vipadenant | Vipadenant is an adenosine A2 receptor antagonists used as an immunosuppressant. Group: Pharmaceutical. CAS No. 442908-10-3. Pack Sizes: 100 mg. Product ID: B0084-459194. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
